NEW YORK – Invitae reported after the close of the market Wednesday that its fourth quarter 2020 revenues increased 51 percent from the prior year.
For the three months ended Dec. 31, 2020, Invitae reported $100.4 million in revenues compared to $66.3 million in Q4 2019, exceeding the consensus Wall Street estimate of $98.4 million. Invitae reported testing revenue of $96.8 million for the quarter, as well as $3.6 million in other revenue.
Invitae billed for 238,000 tests in Q4 2020, but it has stopped reporting accessioned samples.